Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Ранг среди акций #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Цена акции
$0.00001
Последняя синхронизация: 2025-12-30
Рыночная капитализация
$6.89K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля AVAX Technologies, Inc. (AVXT)

Категория

История цены акций AVAX Technologies, Inc. (AVXT)
Наивысшая цена закрытия: $0.00 2025-12-01

Наименьшая цена закрытия: $5.70 1997-05-01
История цены акций AVAX Technologies, Inc. с 1997 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 0.00%
2025 0.00%
2024 -90.00%
2023 0.00%
2022 -29.03%
2021 -92.02%
2020 29.21%
2019 62.70%
2018 -57.93%
2017 -45.69%
2016 -85.27%
2015 184.66%
2014 150.18%
2013 -39.36%
2012 -82.52%
2011 -23.65%
2010 -61.01%
2009 671.71%
2008 -87.28%
2007 -15.34%
2006 -53.45%
2005 27.11%
2004 26.14%
2003 -8.09%
2002 -67.56%
2001 -85.17%
2000 -25.37%
1999 125.74%
1998 -36.11%
1997 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.46%
KR